亚洲免费在线观看_亚洲无码国产精品_亚洲蜜桃精久久久久久久久久久久_欧美性猛交XXXXX水多

掃碼關(guān)注公眾號           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  關(guān)于我們  聯(lián)系我們
亚洲AV无码国产精品午夜久久a,AV免费一区二区三区
OPN Antibody Blocking Peptide (bs-0019P)  
訂購熱線:400-901-9800
訂購郵箱:sales@bioss.com.cn
訂購QQ:  400-901-9800
技術(shù)支持:techsupport@bioss.com.cn
500ug/880.00元
大包裝/詢價(jià)
產(chǎn)品編號 bs-0019P
英文名稱 OPN Antibody Blocking Peptide
中文名稱 骨橋蛋白/分泌型磷蛋白1封閉多肽
別    名 BNSP; Bone sialoprotein 1; BSP I; BSPI; Early T lymphocyte activation 1; ETA 1; ETA1; MGC110940; Nephropontin; OPN; osteopontin/immunoglobulin alpha 1 heavy chain constant region fusion protein; OSTP_HUMAN; secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1); Secreted phosphoprotein 1; SPP 1; SPP-1; SPP1; SPP1/CALPHA1 fusion; Urinary stone protein; Uropontin.   
Specific References  (2)     |     bs-0019P has been referenced in 2 publications.
[IF=13.273] Fangyu Qiao. et al. 4-Octyl itaconate modified demineralized bone matrix scaffold improves bone repair by regulating early inflammation. Chem Eng J. 2021 Dec;425:131490  WB ;  Rat.  
[IF=1.785] Yongquan Huang. et al. Psoralen accelerates osteogenic differentiation of human bone marrow mesenchymal stem cells by activating the TGF?β/Smad3 pathway. Exp Ther Med. 2021 Sep;22(3):1-9  WB ;  Human.  
克 隆 號
理論分子量 kDa
檢測分子量
性    狀 Lyophilized
物    種 human
純化方法 1
活性 Not tested
保存條件 Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
產(chǎn)品介紹 Osteopontin is the principal phosphorylated glycoprotein of bone and is expressed in a limited number of other tissues including dentine. Osteopontin is produced by osteoblasts under stimulation by calcitriol and binds tightly to hydroxyapatite. It is also involved in the anchoring of osteoclasts to the mineral of bone matrix via the vitronectin receptor, which has specificity for osteopontin. Osteopontin is overexpressed in a variety of cancers, including lung, breast, colorectal, stomach, ovarian, melanoma and mesothelioma.

版權(quán)所有 2004-2026 cqshengou.com 北京博奧森生物技術(shù)有限公司
通過國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網(wǎng)安備110107000727號